enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Lymphokine-activated killer cell - Wikipedia

    en.wikipedia.org/wiki/Lymphokine-activated...

    In cell biology, a lymphokine-activated killer cell (also known as a LAK cell) is a white blood cell, consisting mostly of natural killer, natural killer T, and T cells that has been stimulated to kill tumor cells, but because of the function in which they activate, and the cells they can successfully target, they are classified as different than the classical natural killer and T lymphocyte ...

  3. Immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Immunotherapy

    [5] [6] Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells, and cytotoxic T lymphocytes work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells. Vaccine-induced immunity to COVID-19 relies mostly on an immunomodulatory T-cell response.

  4. Cytotoxic T cell - Wikipedia

    en.wikipedia.org/wiki/Cytotoxic_T_cell

    Antigen presentation stimulates T cells to become either "cytotoxic" CD8+ cells or "helper" CD4+ cells.. A cytotoxic T cell (also known as T C, cytotoxic T lymphocyte, CTL, T-killer cell, cytolytic T cell, CD8 + T-cell or killer T cell) is a T lymphocyte (a type of white blood cell) that kills cancer cells, cells that are infected by intracellular pathogens such as viruses or bacteria, or ...

  5. Cancer immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cancer_immunotherapy

    T-cell transfer therapy: a treatment that takes T-cells from the tumor and selects or changes them in the lab to better attack cancer cells, then reintroduces them into the patient. Monoclonal antibodies : designed to bind to specific targets on cancer cells, marking cancer cells so that they will be better seen and destroyed by the immune system.

  6. Cellular adoptive immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cellular_adoptive...

    T cell Efficacy of treatment highly depends on whether infused cells can persist within patients. Increasing the T - cell persistence has been a major challenge and direction for TCR therapy. [7] Tumor microenvironment Tumor microenvironments are usually immunosuppressive. They attract immunosuppressive cells and promote cancer cell survival.

  7. Autologous immune enhancement therapy - Wikipedia

    en.wikipedia.org/wiki/Autologous_immune...

    Cancer cells are formed in our body almost every day but we are not affected by them. This is because they are immediately destroyed by the body's immune system. The immune system is a complex network of cells and organs comprising lymphocytes, macrophages, Dendritic cells, Natural Killer cells (NK Cell), Cytotoxic T Lymphocytes (CTL), etc., that work together to defend the body against ...

  8. T cell receptor T cell therapy - Wikipedia

    en.wikipedia.org/wiki/T_cell_receptor_T_cell_therapy

    Each T cell's TCR is specific to one antigen and sits on the T cell's surface. The affinity of human TCRs to tumor antigens is relatively low, rendering them unable to recognize and kill tumor cells effectively. The modified T cell has much higher affinity, which enhances both recognition and affinity supporting the recognition of tumor cells. [1]

  9. T cell - Wikipedia

    en.wikipedia.org/wiki/T_cell

    Superresolution image of a group of cytotoxic T cells surrounding a cancer cell. Cytotoxic T cells (T C cells, CTLs, T-killer cells, killer T cells) destroy virus-infected cells and tumor cells, and are also implicated in transplant rejection. These cells are defined by the expression of the CD8 protein on their cell surface.